Found: 23
Select item for more details and to access through your institution.
Osteopontin and its downstream carcinogenic molecules: regulatory mechanisms and prognostic value in cancer progression.
- Published in:
- Neoplasma, 2022, v. 69, n. 6, p. 1253, doi. 10.4149/neo_2022_220507N489
- By:
- Publication type:
- Article
The role of SPDEF in cancer: promoter or suppressor.
- Published in:
- Neoplasma, 2022, v. 69, n. 6, p. 1270, doi. 10.4149/neo_2022_220529N571
- By:
- Publication type:
- Article
Cancer-associated fibroblasts subtypes and role in invasion and metastasis of gastric cancer.
- Published in:
- Neoplasma, 2022, v. 69, n. 6, p. 1277, doi. 10.4149/neo_2022_220513N511
- By:
- Publication type:
- Article
Differences in tolerogenic status of NK cells between luminal A type, luminal B type, and triple-negative breast cancer.
- Published in:
- Neoplasma, 2022, v. 69, n. 6, p. 1289, doi. 10.4149/neo_2022_220615N635
- By:
- Publication type:
- Article
HOXC10 indicates poor survival outcome in gastric cancer and promotes G1/S cell cycle transition through transcriptional repression of p21.
- Published in:
- Neoplasma, 2022, v. 69, n. 6, p. 1303, doi. 10.4149/neo_2022_220609N615
- By:
- Publication type:
- Article
Mutational landscape of DNA damage response deficiency-related genes and its association with immune biomarkers in esophageal squamous cell carcinoma.
- Published in:
- Neoplasma, 2022, v. 69, n. 6, p. 1314, doi. 10.4149/neo_2022_220721N738
- By:
- Publication type:
- Article
PRKAA1, stabilized by FTO in an m6A-YTHDF2-dependent manner, promotes cell proliferation and glycolysis of gastric cancer by regulating the redox balance.
- Published in:
- Neoplasma, 2022, v. 69, n. 6, p. 1338, doi. 10.4149/neo_2022_220714N714
- By:
- Publication type:
- Article
PHF21A expression as a biomarker of hepatocellular carcinoma progression and prognosis.
- Published in:
- Neoplasma, 2022, v. 69, n. 6, p. 1349, doi. 10.4149/neo_2022_220807N806
- By:
- Publication type:
- Article
miR-550a-5p promotes the proliferation and migration of hepatocellular carcinoma by targeting GNE via the Wnt/ß-catenin signaling pathway.
- Published in:
- Neoplasma, 2022, v. 69, n. 6, p. 1359, doi. 10.4149/neo_2022_220727N774
- By:
- Publication type:
- Article
SUMO1-modified DNA methyltransferase 1 induces DNA hypermethylation of VWC2 in the development of colorectal cancer.
- Published in:
- Neoplasma, 2022, v. 69, n. 6, p. 1373, doi. 10.4149/neo_2022_220817N841
- By:
- Publication type:
- Article
GDF11 knockdown downregulates SMURF1 to inhibit breast cancer progression by activation of p53 and inactivation of ERa signaling.
- Published in:
- Neoplasma, 2022, v. 69, n. 6, p. 1386, doi. 10.4149/neo_2022_220607N601
- By:
- Publication type:
- Article
Stanniocalcin1 knockdown induces ferroptosis and suppresses glycolysis in prostate cancer via the Nrf2 pathway.
- Published in:
- Neoplasma, 2022, v. 69, n. 6, p. 1396, doi. 10.4149/neo_2022_220626N665
- By:
- Publication type:
- Article
LncRNA CBR3-AS1 predicts a poor prognosis and promotes cervical cancer progression through the miR-3163/LASP1 pathway.
- Published in:
- Neoplasma, 2022, v. 69, n. 6, p. 1406, doi. 10.4149/neo_2022_220730N784
- By:
- Publication type:
- Article
TLR2 and TLR4 in colorectal cancer: relationship to tumor necrosis and markers of systemic inflammation.
- Published in:
- Neoplasma, 2022, v. 69, n. 6, p. 1418, doi. 10.4149/neo_2022_220509N498
- By:
- Publication type:
- Article
Moderately hypofractionated salvage radiotherapy in patients with biochemical recurrence of prostate cancer after prostatectomy: long-term results and comparative analysis of two schedules.
- Published in:
- Neoplasma, 2022, v. 69, n. 6, p. 1425, doi. 10.4149/neo_2022_220825N864
- By:
- Publication type:
- Article
The prognostic impact of immune checkpoint inhibitors for the treatment of pulmonary sarcomatoid carcinoma: A multicenter retrospective study.
- Published in:
- Neoplasma, 2022, v. 69, n. 6, p. 1437, doi. 10.4149/neo_2022_220617N644
- By:
- Publication type:
- Article
Safety and efficacy of the FLOT regimen in the Polish population - an analysis of the prospective trial.
- Published in:
- Neoplasma, 2022, v. 69, n. 6, p. 1445, doi. 10.4149/neo_2022_220720N734
- By:
- Publication type:
- Article
Evaluation of serum glucose-regulated protein 78 (GRP78) as a biomarker of treatment response to bortezomib-based induction regimen in multiple myeloma: A cross-sectional pilot study.
- Published in:
- Neoplasma, 2022, v. 69, n. 6, p. 1451, doi. 10.4149/neo_2022_220526N564
- By:
- Publication type:
- Article
Correlation between gastritis cystica profunda and the risk of lymph node metastasis in early gastric cancer.
- Published in:
- Neoplasma, 2022, v. 69, n. 6, p. 1459, doi. 10.4149/neo_2022_220314N281
- By:
- Publication type:
- Article
Burkitt lymphoma-a retrospective analysis of data from the Registry of the Czech Lymphoma Study Group with external validation of the Burkitt lymphoma International Prognostic Index.
- Published in:
- Neoplasma, 2022, v. 69, n. 6, p. 1466, doi. 10.4149/neo_2022_221030N1064
- By:
- Publication type:
- Article
Real-world evidence of efficacy and safety of pomalidomide and dexamethasone in relapsed/refractory multiple myeloma patients: Czech registry data.
- Published in:
- Neoplasma, 2022, v. 69, n. 6, p. 1474, doi. 10.4149/neo_2022_220813N827
- By:
- Publication type:
- Article
Clinical characteristics and prognostic value of EGFR mutation in stage I lung adenocarcinoma with spread through air spaces after surgical resection.
- Published in:
- Neoplasma, 2022, v. 69, n. 6, p. 1480, doi. 10.4149/neo_2022_220619N649
- By:
- Publication type:
- Article
Mast cells as a tumor microenvironment factor associated with the aggressiveness of prostate cancer.
- Published in:
- Neoplasma, 2022, v. 69, n. 6, p. 1490, doi. 10.4149/neo_2022_221014N1020
- By:
- Publication type:
- Article